Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer.
about
Recent clinical trials of cancer immunogene therapy in companion animals.Cell-Specific Requirements for STAT Proteins and Type I IFN Receptor Signaling Discretely Regulate IL-24 and IL-10 Expression in NK Cells and Macrophages.Ultrasound-mediated microbubble destruction: a new method in cancer immunotherapyCombination of Suicide and Cytokine Gene Therapies as Surgery Adjuvant for Canine Mammary Carcinoma
P2860
Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Intratumoural interleukin 12 g ...... dogs with spontaneous cancer.
@en
Intratumoural interleukin 12 g ...... dogs with spontaneous cancer.
@nl
type
label
Intratumoural interleukin 12 g ...... dogs with spontaneous cancer.
@en
Intratumoural interleukin 12 g ...... dogs with spontaneous cancer.
@nl
prefLabel
Intratumoural interleukin 12 g ...... dogs with spontaneous cancer.
@en
Intratumoural interleukin 12 g ...... dogs with spontaneous cancer.
@nl
P2093
P2860
P356
P1476
Intratumoural interleukin 12 g ...... dogs with spontaneous cancer.
@en
P2093
H de Rooster
K Vanderperren
L Cicchelero
L Van Brantegem
N N Sanders
P2860
P304
P356
10.1111/VCO.12255
P577
2016-08-09T00:00:00Z